Circulating level of hepatocyte growth factor predicts incidence of type 2 diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis (MESA)
- 1 March 2016
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 65 (3) , 64-72
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Independent association of elevated serum hepatocyte growth factor levels with development of insulin resistance in a 10‐year prospective studyClinical Endocrinology, 2013
- Serum Hepatocyte Growth Factor and Cancer Mortality in an Apparently Healthy Japanese PopulationJournal of Epidemiology, 2012
- A hepatocyte growth factor receptor (Met)−insulin receptor hybrid governs hepatic glucose metabolismNature Medicine, 2011
- Trends in the Prevalence of Type 2 Diabetes in Asians Versus WhitesDiabetes Care, 2011
- Hepatocyte Growth Factor and Clinical Diabetes in Postmenopausal WomenDiabetes Care, 2010
- Hepatocyte Growth Factor Is a Novel Stimulator of Glucose Uptake and Metabolism in Skeletal Muscle CellsJournal of Biological Chemistry, 2008
- Diabetes, Hypertension, and Dyslipidemia in Mexican Americans and Non-Hispanic WhitesAmerican Journal of Preventive Medicine, 2006
- Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failureAmerican Heart Journal, 2005
- Multi-Ethnic Study of Atherosclerosis: Objectives and DesignAmerican Journal of Epidemiology, 2002
- Assessing the use of medications in the elderly: Methods and initial experience in the cardiovascular health studyJournal of Clinical Epidemiology, 1992